Regulatory
Chemi Nutra granted patent for phosphatidic acid to support muscle mass and strength
December 23rd 2020Chemi Nutra has been granted a new patent (United States Patent 10,869,843) for phosphatidic acid, claiming that its branded Mediator PA can increase muscle mass and strength when accompanied with resistance exercise.
FTC cracks down on unsubstantiated CBD claims
December 22nd 2020FTC is taking action against six companies for allegedly making a wide range of scientifically unsubstantiated claims regarding CBD’s ability to treat serious health conditions such as cancer, heart disease, hypertension, and Alzheimer’s.
KGK Science provides path-to-market strategy for Psyched Wellness novel mushroom extract
December 18th 2020KGK Science has been contracted by Psyched Wellness, a Canadian health supplement company, to provide a regulatory package of services to support the launch of its Amanita muscaria mushroom extract in the U.S. and Canada.
CRN calls for consistent, harmonized CBD regulation between states based on federal frameworks
December 17th 2020The Council for Responsible Nutrition recently submitting comments regarding the Proposed Kentucky Administrative Regulation 902 KAR 45:190, hemp-derived cannabidiol products and labeling requirements.
CRN responds to FDA’s sudden policy change on supplements containing N-acetyl-L-cysteine
December 8th 2020The Council for Responsible Nutrition has responded to FDA regarding recent warning letters from the Agency alleging that N-acetyl-L-cysteine (NAC) is not a dietary supplement, and therefore prohibited from being marketed as such under the Federal Food, Drug, and Cosmetic Act.
BAPP issues revised SOP for irreparably defective articles, opens public comment
December 3rd 2020The Botanical Adulterants Prevention Program (BAPP) issued its revised draft of "Best Practices Contract Language and Standard Operating Procedure (SOP) Templates for the Disposal/Destruction of Irreparably Defective Articles."
GanedenBC30 approved for health claim in Brazil
November 17th 2020GanedenBC30, a spore-forming probiotic ingredient by Kerry, was approved by Brazilian regulatory agency, ANVISA, for the following health claim: “Bacillus coagulans GBI-30, 6086 can contribute to the health of the gastrointestinal tract.”
Sabinsa strengthens position in Canada with three new patents and an NPN from Health Canada
October 28th 2020Sabinsa has been granted three new patents as well as an additional Natural Products Number (NPN) issued by Health Canada, bringing Sabinsa’s total number of products with health claims in Canada to 37.
NARB recommends Benefiber discontinue ‘100% natural’ and ‘cravings’ claims
October 26th 2020A panel of the National Advertising Review Board recommended GlaxoSmithKline Consumer Healthcare, LLC discontinue “100% natural” and “clinically proven to curb cravings” claims for Benefiber Original and Benefiber Healthy Shape (Benefiber).
FDA’s Tave outlines obstacles to dietary supplement market enforcement at CRN’s Virtual Conference
October 16th 2020Is there a way to strengthen FDA’s regulatory enforcement of dietary supplements? FDA’s Steven Tave discussed the obstacles at CRN’s virtual “NOW, NEW, NEXT” conference on October 14—and industry responded.